Breaking News - The Fly

Open Search

RVPH

Reviva Pharmaceuticals

$

()

Reviva Pharmaceuticals announces FDA alignment on brilaroxazine trial

RVPH

4/15/2024 - 08:35am

Reviva Pharmaceuticals announces anticipated milestones, events

RVPH

4/15/2024 - 08:09am

Reviva Pharmaceuticals reports 2023 EPS ($1.65), consensus ($1.63)

RVPH

4/15/2024 - 08:07am

Reviva Pharmaceuticals to host KOL event to discuss data on brilaroxazine

RVPH

2/6/2024 - 08:17am

Reviva Pharmaceuticals files $200M mixed securities shelf

RVPH

2/2/2024 - 16:39pm

Reviva Pharmaceuticals provides program updates, upcoming milestones

RVPH

1/4/2024 - 08:23am

Karuna downgraded, Arm target raised: Wall Street's top analyst calls

KRTX , BMY , CERE

…

12/26/2023 - 10:04am

Reviva may be most undervalued in neurology, says H.C. Wainwright

RVPH , KRTX , CERE

12/26/2023 - 06:13am

Karuna Therapeutics just downgraded at H.C. Wainwright, here's why

KRTX , BMY , AXSM

…

12/26/2023 - 06:06am

Largest borrow rate increases among liquid names

UMC , SIRI , UPST

…

11/21/2023 - 08:45am

Reviva to sell 5.85M shares at $5.125 in registered direct offering

RVPH

11/16/2023 - 08:07am

Reviva Pharmaceuticals reports Q3 EPS (44c), consensus (37c)

RVPH

11/14/2023 - 16:05pm

Reviva Pharmaceuticals Holdings options imply 7.7% move in share price post-earnings

RVPH

11/14/2023 - 13:34pm

Reviva Pharmaceuticals Holdings options imply 10.5% move in share price post-earnings

RVPH

11/13/2023 - 13:34pm

Reviva Pharmaceuticals price target raised to $20 from $10 at H.C. Wainwright

RVPH

10/31/2023 - 06:15am